Dana Silber McMahon

Dana Silber McMahon

VP & Global Chief Compliance Officer at Stryker | Expert in Enterprise Risk Management Strategy | Board Advisor

Stryker

View LinkedIn Profile
Experience27+ Years
LevelCXO

Executive Overview

Dana Silber McMahon is an expert in enterprise risk management strategy and serves as Vice President and Global Chief Compliance Officer at Stryker. She leads integrated Compliance and Enterprise Risk functions for the $25B global medical technology company operating in 75 countries. Her work focuses on connecting risk assessment, regulatory insight, ethical judgment, and a culture of integrity, inclusion, and high performance to the company's strategic direction, operating plans, and decisions across all business functions. Dana also plays a key role as a board advisor, providing insight on enterprise risk management, regulatory shifts, global operations, and technology-driven issues. She has led significant initiatives to unify compliance and risk activities across regions, embed risk awareness into strategic planning, and strengthen Stryker's ability to operate responsibly and resiliently in complex markets. She is also the President of the Stryker Women's Network. Her career spans more than 20 years in the life sciences industry, including senior legal leadership roles at Novo Nordisk and early practice at O'Melveny & Myers. Dana is known for translating complexity into clarity, integrating risk and strategy, and fostering a culture of integrity, inclusion, accountability, and high performance across global teams. SPECIALTIES Enterprise Risk Management Strategy / Global Compliance Leadership / Board Advisory / Ethics, Integrity & Inclusion / Culture & Organizational Resilience / Strategic Risk Integration / Regulatory Strategy / Cross-Functional Decision Support / AI, Cyber & Privacy Risk Integration

Career Timeline

Professional employment history
  • StrykerCurrent
    Jun 2017–Present· 9 yrs 3 mos
    • Vice President, Global Chief Compliance Officer, Head of Enterprise RiskCurrent
      Jun 2020–Present
    • Vice President, Global Chief Compliance Officer, Head of Privacy and Enterprise Risk, Transformed Compliance
      Jun 2020–Jun 2026
    • Chief Legal Counsel — Restructured & Led Global Legal Team to Advise Entire MedTech Company
      Jun 2017–Jun 2020
  • 2013–May 2017· 4 yrs 4 mos
    • Assistant General Counsel | Sr. Corporate Counsel | Corporate Counsel | Senior Attorney | Attorney
      2013–May 2017
  • 2003–May 2017· 14 yrs 4 mos
    • Assistant General Counsel — Member of leadership team; supported launch of 1st obesity drug
      2013–May 2017
    • Senior Corporate Counsel — Instrumental in Successful Launch of 2 Blockbuster Drugs
      2010–2013
    • Counsel, Corporate
      2008–2010
    • Senior Attorney — Appointed to leadership team for diabetes franchise
      2005–2008
    • Attorney II — Established Company’s Employment Law Group
      2003–2005
  • Sep 1999–2003· 3 yrs 4 mos
    • Associate
      Sep 1999–2003

Education

Doctor of Law (J.D.)

New York University School of Law

Bachelor of Arts (B.A.)

English

Hamilton College

Certificate of Professional Development

The Wharton School, University of Pennsylvania

Executive Relationship Map

Reports To
Dana Silber McMahon
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
ComplianceRegulatory AffairsMergers & Acquisitions (M&A)LeadershipSales EffectivenessProduct LaunchManagementDiabetesHealthcare ComplianceHealthcareC-Suite and Board RelationsNegotiationStrategic PlanningMedical DevicesCross-functional Team LeadershipTurnaround LeadershipOrganizational RestructuringCommercial LawPharmaceutical IndustryMarket Access